HUP9901438A3 - Therapeutic pyrimidine compounds - Google Patents

Therapeutic pyrimidine compounds

Info

Publication number
HUP9901438A3
HUP9901438A3 HU9901438A HUP9901438A HUP9901438A3 HU P9901438 A3 HUP9901438 A3 HU P9901438A3 HU 9901438 A HU9901438 A HU 9901438A HU P9901438 A HUP9901438 A HU P9901438A HU P9901438 A3 HUP9901438 A3 HU P9901438A3
Authority
HU
Hungary
Prior art keywords
therapeutic
pyrimidine compounds
pyrimidine
compounds
therapeutic pyrimidine
Prior art date
Application number
HU9901438A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Oxford Glycosciences Uk Ltd Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9512868.2A external-priority patent/GB9512868D0/en
Priority claimed from GBGB9608372.0A external-priority patent/GB9608372D0/en
Priority claimed from GBGB9608547.7A external-priority patent/GB9608547D0/en
Application filed by Oxford Glycosciences Uk Ltd Ab filed Critical Oxford Glycosciences Uk Ltd Ab
Publication of HUP9901438A2 publication Critical patent/HUP9901438A2/hu
Publication of HUP9901438A3 publication Critical patent/HUP9901438A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Pyrane Compounds (AREA)
HU9901438A 1995-06-23 1996-06-24 Therapeutic pyrimidine compounds HUP9901438A3 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9512868.2A GB9512868D0 (en) 1995-06-23 1995-06-23 Therapeutic compounds
GBGB9608372.0A GB9608372D0 (en) 1996-04-23 1996-04-23 Therapeutic compounds
GBGB9608547.7A GB9608547D0 (en) 1996-04-25 1996-04-25 Therapeutic compounds
US1676296P 1996-05-03 1996-05-03
US1697396P 1996-05-07 1996-05-07

Publications (2)

Publication Number Publication Date
HUP9901438A2 HUP9901438A2 (hu) 1999-08-30
HUP9901438A3 true HUP9901438A3 (en) 2000-07-28

Family

ID=27517294

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901438A HUP9901438A3 (en) 1995-06-23 1996-06-24 Therapeutic pyrimidine compounds

Country Status (16)

Country Link
US (1) US5945406A (de)
EP (1) EP0851866B1 (de)
JP (1) JPH11507942A (de)
KR (1) KR19990028344A (de)
CN (1) CN1196059A (de)
AT (1) ATE204878T1 (de)
AU (1) AU6234296A (de)
CA (1) CA2225247A1 (de)
DE (1) DE69614867T2 (de)
ES (1) ES2162078T3 (de)
HU (1) HUP9901438A3 (de)
ID (1) ID16479A (de)
IL (1) IL122700A0 (de)
NO (1) NO976043L (de)
PL (1) PL328266A1 (de)
WO (1) WO1997000882A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11507942A (ja) * 1995-06-23 1999-07-13 オックスフォード グリコサイエンセス（ユーケー） リミテッド 治療用化合物
DE19741738A1 (de) * 1997-09-22 1999-03-25 Hoechst Ag Linker-Nucleosid, seine Herstellung und Verwendung
DE19741715A1 (de) 1997-09-22 1999-03-25 Hoechst Ag Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung
DE19837387A1 (de) 1998-08-18 2000-02-24 Aventis Res & Tech Gmbh & Co 3'-Desoxypentopyranosyl-Nucleinsäure, ihre Herstellung und Verwendung
US6344460B1 (en) * 1999-03-19 2002-02-05 Lonza Inc. Propynyl uracils
US20050143300A1 (en) * 2003-10-10 2005-06-30 Ma Jian-Xing Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
HUE033210T2 (hu) * 2008-07-11 2017-11-28 Univ Texas Rákellenes aktivitású 2-dezoxi-monoszacharidok új acetátjai
EP3939595A1 (de) 2013-04-05 2022-01-19 Board of Regents, The University of Texas System Ester von 2-deoxymonosacchariden mit antiproliferativer wirkung

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354160A (en) * 1965-07-22 1967-11-21 Hoffmann La Roche Tri-lower alkyl-silyl-5-fluoropyrimidines
US4248999A (en) * 1976-10-28 1981-02-03 Sankyo Company Limited 5-Fluorouracil derivatives and process for preparing thereof
DK149818C (da) * 1976-10-28 1987-04-06 Sankyo Co Analogifremgangsmaade til fremstilling af 5-fluoruracil-derivater
JPS55153796A (en) * 1979-05-21 1980-11-29 Meiji Seika Kaisha Ltd 5-fluorouracil nucleoside and its preparation
JPS5829798A (ja) * 1981-08-15 1983-02-22 Tetsuo Suami ヌクレオシド類似体
JPS5872599A (ja) * 1981-10-27 1983-04-30 Kanto Ishi Pharma Co Ltd 複合糖質誘導体
EP0119650A3 (de) * 1983-03-21 1987-09-30 THE PROCTER & GAMBLE COMPANY Galactosyl-Insulin-Konjugate für die Behandlung von Zuckerkranken
JP2696393B2 (ja) * 1989-05-09 1998-01-14 株式会社日本抗体研究所 チミン誘導体及びこれを含有する抗ｈｉｖ剤
JPH0517494A (ja) * 1991-07-10 1993-01-26 Nippon Shoji Kk グルコサミン誘導体
DE69533856T2 (de) * 1994-10-24 2005-12-08 Genencor International, Inc., Palo Alto L-pyranosyl-nukleoside
JPH11507942A (ja) * 1995-06-23 1999-07-13 オックスフォード グリコサイエンセス（ユーケー） リミテッド 治療用化合物
GB9626450D0 (en) * 1996-12-20 1997-02-05 Oxford Glycosciences Uk Ltd Therapeutic compounds

Also Published As

Publication number Publication date
JPH11507942A (ja) 1999-07-13
MX9710529A (es) 1998-08-30
HUP9901438A2 (hu) 1999-08-30
IL122700A0 (en) 1998-12-06
EP0851866B1 (de) 2001-08-29
CA2225247A1 (en) 1997-01-09
WO1997000882A1 (en) 1997-01-09
ID16479A (id) 1997-10-02
DE69614867D1 (de) 2001-10-04
AU6234296A (en) 1997-01-22
NO976043L (no) 1998-02-20
US5945406A (en) 1999-08-31
ATE204878T1 (de) 2001-09-15
EP0851866A1 (de) 1998-07-08
DE69614867T2 (de) 2002-04-11
NO976043D0 (no) 1997-12-22
CN1196059A (zh) 1998-10-14
PL328266A1 (en) 1999-01-18
KR19990028344A (ko) 1999-04-15
ES2162078T3 (es) 2001-12-16

Similar Documents

Publication Publication Date Title
ZA983176B (en) Therapeutic compounds
IL131521A0 (en) Pyrimidine derivatives
GB9421709D0 (en) Therapeutic compounds
GR3033744T3 (en) Therapeutic compounds
GB9600143D0 (en) Therapeutic compounds
GB9500691D0 (en) Compounds
GB9506309D0 (en) Pyrimidine compounds
HUP9901438A3 (en) Therapeutic pyrimidine compounds
HU9503012D0 (en) New pyrimidine derivatives
GB9716345D0 (en) Therapeutic compounds
GB9716347D0 (en) Therapeutic compounds
GB9716344D0 (en) Therapeutic compounds
GB9626450D0 (en) Therapeutic compounds
GB2316077B (en) Pyrimidine Compounds
GB9515060D0 (en) Therapeutic heterocyclic compounds
GB9512868D0 (en) Therapeutic compounds
GB9523558D0 (en) Therapeutic compounds
GB9523801D0 (en) Therapeutic compounds
GB9526110D0 (en) Therapeutic compounds
GB9521463D0 (en) Therapeutic heterocyclic compounds
GB9509419D0 (en) Therapeutic heterocyclic compounds
GB9515305D0 (en) Therapeutic heterocyclic compounds
PL310059A1 (en) Therapeutic oinment
GB9705401D0 (en) Therapeutic compounds
GB9716111D0 (en) Therapeutic compounds